Medicines Evaluation Unit
Manchester, United Kingdom
Research institute in Wythenshawe, England
The Langley Bldg, Southmoor Rd, Roundthorn Industrial Estate, Wythenshawe, Manchester M23 9QZ
About Medicines Evaluation Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Chiesi Farmaceutici S.p.A.
13
Boehringer Ingelheim
7
Verona Pharma plc
4
Vertex Pharmaceuticals Incorporated
4
Bayer
2
CSL Behring
2
EpiEndo Pharmaceuticals
2
Mannkind Corporation
2
Proteostasis Therapeutics, Inc.
2
Pulmatrix Inc.
2
AV7 Limited
1
Clinical Trials at Medicines Evaluation Unit
During the past decade, Medicines Evaluation Unit conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 14 clinical trials were completed, i.e. on
average, 28% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.
2002-05-01
Completed
653
Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD
2008-02-01
2009-01-01
Completed
91
A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics
2008-05-01
2008-12-01
Completed
30
IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study
2008-07-01
2009-05-01
Unknown status
50
Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in Asthmatics
2009-09-01
2010-02-01
Completed
87
A Study to Evaluate Insulin in the Blood After Inhalation of a Dry Powder Insulin Formulation (Called Technosphere®/Insulin) in Non-diabetic Patients With & Without Chronic Obstructive Pulmonary Disease (COPD)
2006-07-01
2008-11-01
Completed
39
Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)
2010-06-25
2016-09-26
Completed
198
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Medicines Evaluation Unit" #1 sponsor was "Chiesi Farmaceutici S.p.A." with 13 trials, followed by "Boehringer Ingelheim" with 7 trials
sponsored, "Verona Pharma plc" with 4 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 4 trials sponsored and "Bayer"
with 4 trials sponsored. Other sponsors include 38 different institutions and
companies that sponsored additional 43 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Medicines Evaluation Unit"
#1 collaborator was "Ario Pharma Ltd" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Chiesi UK" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator and "FGK Clinical Research GmbH" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Medicines Evaluation Unit
According to Clinical.Site data, the most researched conditions in "Medicines Evaluation Unit" are
"Asthma" (18 trials), "Chronic Obstructive Pulmonary Disease" (10 trials), "COPD" (7 trials), "Cystic Fibrosis" (7 trials) and "Chronic Obstructive Pulmonary Disease (COPD)" (6 trials). Many other conditions were trialed in "Medicines Evaluation Unit" in a lesser frequency.
Clinical Trials Intervention Types at Medicines Evaluation Unit
Most popular intervention types in "Medicines Evaluation Unit" are "Drug" (72 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (37 trials), "Glycopyrrolate" (3 trials), "BI 443651" (2 trials), "EP395" (2 trials) and "IVA" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Medicines Evaluation Unit
The vast majority of trials in "Medicines Evaluation Unit" are
73 trials for "All" genders.
Clinical Trials Status at Medicines Evaluation Unit
Currently, there are NaN active trials in "Medicines Evaluation Unit".
undefined are not yet recruiting,
8 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 60 completed trials in Medicines Evaluation Unit,
2 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Medicines Evaluation Unit, 37 "Phase 1"
clinical trials were conducted, 40 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".